Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections

Dr. Edgard Janer

Rheumatology
3355 W Bearss Ave, 
Tampa, FL 
Accepting New Patients
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
3355 W Bearss Ave, 
Tampa, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Edgard Janer is a Rheumatologist in Tampa, Florida. Dr. Janer is rated as an Experienced provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. His top areas of expertise are Synovitis, Rheumatoid Arthritis (RA), Fibromyalgia, and Tenosynovitis. Dr. Janer is currently accepting new patients.

His clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Specialist in FL
Hospital Affiliations
St Josephs Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MMM Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

3355 W Bearss Ave, Tampa, FL 33618

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: July 23, 2024
Intervention Type: Drug, Other
Study Drug: VIB7734
Study Phase: Phase 2
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Completed
Publish Date: November 21, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials
Similar Doctors
Distinguished in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Julio A. Gonzalez-Paoli
Rheumatology
Distinguished in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Julio A. Gonzalez-Paoli
Rheumatology

Ohi West Medical Group Ii LLC

2100 Via Bella Blvd, 
Land O Lakes, FL 
 (8.4 miles away)
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Julio Gonzalez-Paoli is a Rheumatologist in Land O Lakes, Florida. Dr. Gonzalez-Paoli is rated as a Distinguished provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. His top areas of expertise are Rheumatoid Arthritis (RA), MAGIC Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, and IgG4-Related Disease. Dr. Gonzalez-Paoli is currently accepting new patients.

Distinguished in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Abie A. Samuel
Rheumatology
Distinguished in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Abie A. Samuel
Rheumatology

Baycare Medical Group, Inc.

620 10th St N, 
St Petersburg, FL 
 (23.1 miles away)
Languages Spoken:
English, Portuguese, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Abie Samuel is a Rheumatologist in St Petersburg, Florida. Dr. Samuel is rated as a Distinguished provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Her top areas of expertise are Rheumatoid Arthritis (RA), MAGIC Syndrome, IgG4-Related Disease, and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Dr. Samuel is currently accepting new patients.

Distinguished in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Robert W. Levin
Rheumatology
Distinguished in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Robert W. Levin
Rheumatology

American Arthritis And Rheumatology Associates LLC

1831 N Belcher Rd, Suite D2, 
Clearwater, FL 
 (16.5 miles away)
727-734-6631
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Levin is a Rheumatologist in Clearwater, Florida. Dr. Levin is rated as a Distinguished provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. His top areas of expertise are Rheumatoid Arthritis (RA), Light Chain Deposition Disease (LCDD), IgG4-Related Disease, and MAGIC Syndrome. Dr. Levin is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Janer's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 32 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile